So here we are 6 months in to the new CEO's tenure. I thought this might be a good time to assess what has come to pass over the last 6 months
SP has fallen 37% from $0.16 to $0.096
22nd Jan - Agreement with ITROM signed for VIVAGEL - Legacy
29th Jan - VIRALEZE Trail failure - Legacy
19th Feb - FDA Appeal failure - Legacy
1st Mar - Booted from All Ords - Legacy
8th April - Medixci partnership - Potential legacy or Cheryl run partnership)
22nd May - Business update (Cheryl run)
27th May - Positive DEP Iri results (Legacy)
So to date by my reckoning, Cheryl has produced a business update and potentially brokered a partnership with Medecxi.
Personally I was hoping for more from the new CEO.
Agreed that she should be afforded a grace period to be able to come in and pick up the pieces, but the list above does not contain much of substance.......
SPL Price at posting:
9.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)